LP
TNDM icon

LMR Partners’s Tandem Diabetes Care TNDM Stock Holding History

LMR Partners’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-33,824
Closed -$1.43M – 1601
2024
Q3 		$1.43M Buy
33,824
+23,743
+236% +$1.01M 0.01% 680
2024
Q2 		$406K Sell
10,081
-35,877
-78% -$1.5M ﹤0.01% 796
2024
Q1 		$1.63M Buy
45,958
+10,250
+29% +$275K 0.02% 592
2023
Q4 		$1.06M Buy
+35,708
New +$741K 0.01% 577
2023
Q2 		– Sell
-18,069
Closed -$734K – 1112
2023
Q1 		$734K Buy
+18,069
New +$748K 0.01% 654
2020
Q4 		– Sell
-28,801
Closed -$3.27M – 629
2020
Q3 		$3.27M Sell
28,801
-5,083
-15% -$534K 0.07% 108
2020
Q2 		$3.35M Buy
+33,884
New +$2.7M 0.08% 170
2018
Q4 		– Sell
-6,462
Closed -$277K – 479
2018
Q3 		$277K Buy
+6,462
New +$226K 0.02% 265
2017
Q3 		– Sell
-9,183
Closed -$74K – 540
2017
Q2 		$74K Buy
+9,183
New +$84.9K ﹤0.01% 576

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

LMR Partners's TNDM Position: Q4 2024 in Review

LMR Partners sold out of Tandem Diabetes Care (TNDM) in Q4 2024, closing a stake of 33,824 shares — an estimated $1.43M sold.

LMR Partners first reported a position in TNDM in Q2 2017 and held it in 9 quarters. The position peaked at $3.35M in Q2 2020. 316 funds tracked by Wall St. Rank hold TNDM as of Q4 2024.

  • LMR Partners reported no remaining Tandem Diabetes Care position as of Q4 2024 after selling out during the quarter.
  • LMR Partners sold 33,824 Tandem Diabetes Care shares in Q4 2024, an estimated $1.43M.
  • LMR Partners first reported a position in Tandem Diabetes Care in Q2 2017 and held it in 9 quarters.
  • LMR Partners's Tandem Diabetes Care position peaked at $3.35M in Q2 2020.
  • 316 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2024.

Based on LMR Partners's 13F filing for Q4 2024, filed 14 Feb 2025.